C.J. Gelatine Products Ltd.
BSE: CJGEL · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock C.J. Gelatine Products Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
C J Gelatine Products Limited specialises in the manufacturing of pharmaceutical, edible, and industrial-grade gelatine derived from animal bones. The company also produces dicalcium phosphate as a byproduct, serving the pharmaceutical, animal feed, and fertiliser sectors.
Business Model
The company generates revenue through the processing and sale of gelatine products and dicalcium phosphate to domestic and international markets. It operates as a niche manufacturer within the chemical and healthcare supply chain.
- Establishment Year:1980
- Headquarters:Bhopal, Madhya Pradesh
Growth Outlook
Growth is driven by the sustained demand for pharmaceutical-grade gelatine used in capsule shells and tablets. The company leverages its specialised manufacturing capabilities to maintain its position in the niche chemical sector.
Key Risks
- Raw Material Availability. The company relies on the consistent supply of animal bones, which may be subject to supply chain disruptions or regulatory changes.
- Regulatory Compliance. As a manufacturer of pharmaceutical-grade products, the company must adhere to stringent quality and safety standards, increasing operational costs.
- Market Competition. The niche gelatine market faces competition from both domestic and international players, which may impact pricing power and margins.
- Environmental Regulations. Chemical manufacturing processes are subject to evolving environmental laws that may necessitate significant capital expenditure for waste management.
Start your research today
Unlock AI insights, financials, peers and live data on C.J. Gelatine Products Ltd. and 5,000+ companies — free.
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
C.J. Gelatine Products Ltd.CJGEL | ₹12 Cr | — | — | — | 5.4% | — | — | +47.5% |
Kronox Lab Sciences LimitedKRONOX | ₹666 Cr | 23.05 | 16.30 | 6.1% | 38.7% | 27.7% | 35.9% | +11.2% |
Black Rose IndusBLACKROSE | ₹584 Cr | 26.01 | 16.40 | — | 11.0% | 13.9% | 18.9% | +19.1% |
Vipul OrganicsVIPULORG | ₹506 Cr | 63.11 | 30.62 | 7.7% | 10.4% | 8.9% | 13.4% | +29.6% |
Plastiblends India LimitedPLASTIBLEN | ₹493 Cr | 11.54 | 6.83 | 5.5% | 9.2% | 9.7% | 12.8% | +0.5% |
Aarti SurfactantAARTISURF | ₹458 Cr | 24.91 | 9.80 | 25.2% | 6.1% | 7.7% | 12.4% | +19.0% |
As of Mar 2026
Financials
C.J. Gelatine Products Ltd.
BSE: CJGEL · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock C.J. Gelatine Products Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
C J Gelatine Products Limited specialises in the manufacturing of pharmaceutical, edible, and industrial-grade gelatine derived from animal bones. The company also produces dicalcium phosphate as a byproduct, serving the pharmaceutical, animal feed, and fertiliser sectors.
Business Model
The company generates revenue through the processing and sale of gelatine products and dicalcium phosphate to domestic and international markets. It operates as a niche manufacturer within the chemical and healthcare supply chain.
- Establishment Year:1980
- Headquarters:Bhopal, Madhya Pradesh
Growth Outlook
Growth is driven by the sustained demand for pharmaceutical-grade gelatine used in capsule shells and tablets. The company leverages its specialised manufacturing capabilities to maintain its position in the niche chemical sector.
Key Risks
- Raw Material Availability. The company relies on the consistent supply of animal bones, which may be subject to supply chain disruptions or regulatory changes.
- Regulatory Compliance. As a manufacturer of pharmaceutical-grade products, the company must adhere to stringent quality and safety standards, increasing operational costs.
- Market Competition. The niche gelatine market faces competition from both domestic and international players, which may impact pricing power and margins.
- Environmental Regulations. Chemical manufacturing processes are subject to evolving environmental laws that may necessitate significant capital expenditure for waste management.
Start your research today
Unlock AI insights, financials, peers and live data on C.J. Gelatine Products Ltd. and 5,000+ companies — free.
Peers · Specialty Chemicals
As of Mar 2026